Option Chain

AbCellera Biologics Inc

ABCLNASDAQ · USD

11.88USD+0.75 (+6.74%)

2310

AbCellera Biologics Inc (ABCL) Option Chain

AbCellera Biologics Inc trades at $11.88, up 6.74%, with an IV Rank of 66.67%. This is average versus the past year, and the company carries a market cap of $3,607M in the Biotechnology industry. On the Nov 20, 2026 chain, the at the money $12.00 strike shows calls at $0.60 / $0.85 and puts at $1.40 / $1.85, both carrying about $1.12 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $16.00 calls, at 276 contracts, and the $11.00 puts, at 164, as of Nov 5, 2026.

Tracking the ABCL option chain helps you see every strike and expiry on AbCellera Biologics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABCL options activity at a glance. Use our scanner to monitor the ABCL option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABCL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ABCL options are being actively traded, and where they are not.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
36.23	28	1	0.74	1.88	1.45	3.80	10.00	-10.15	0.15	0.80	0.00	0.48	123	1,035	63.77
52.33	41	2	0.44	0.88	0.90	1.75	11.00	-1.17	0.90	1.00	0.00	0.95	164	3,623	47.67
66.76	2,491	36	0.73	0.00	0.60	0.85	12.00	+7.82	1.40	1.85	0.12	1.51	3	697	33.24
78.18	3,126	2	0.45	0.00	0.15	0.75	13.00	+16.80	1.65	2.85	1.12	1.13	105	707	21.82
86.38	1,094	36	0.25	0.00	0.20	0.30	14.00	+25.79	1.40	4.70	2.12	0.93	0	293	13.62

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV Rank66.67% Moderate
Market cap (M$)3,607
52 weeks high-25.90%
52 weeks low306.20%
Analyst recommendationStrong Buy
1.14
Target price$17.17
41.58% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-09
P/E—
Future P/E—
EPS (ttm)-0.54
EPS growth next 5 years-16.72%

As of Nov 5, 2026

Browse all Option Chain tickers